South Korea · Delayed Price · Currency is KRW Aprogen Medicines Statistics
Total Valuation
KRX:007460 has a market cap or net worth of KRW 90.40 billion. The enterprise value is 527.81 billion.
| Market Cap | 90.40B |
| Enterprise Value | 527.81B |
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KRX:007460 has 20.57 million shares outstanding. The number of shares has increased by 15.24% in one year.
| Current Share Class | 20.57M |
| Shares Outstanding | 20.57M |
| Shares Change (YoY) | +15.24% |
| Shares Change (QoQ) | +2.23% |
| Owned by Insiders (%) | 6.93% |
| Owned by Institutions (%) | 1.96% |
| Float | 12.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.77 |
| PB Ratio | 0.20 |
| P/TBV Ratio | 1.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.52 |
| EV / Sales | 4.47 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -12.67 |
Financial Position
The company has a current ratio of 0.97, with a Debt / Equity ratio of 0.41.
| Current Ratio | 0.97 |
| Quick Ratio | 0.44 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.51 |
| Interest Coverage | -20.06 |
Financial Efficiency
Return on equity (ROE) is -31.28% and return on invested capital (ROIC) is -15.83%.
| Return on Equity (ROE) | -31.28% |
| Return on Assets (ROA) | -9.00% |
| Return on Invested Capital (ROIC) | -15.83% |
| Return on Capital Employed (ROCE) | -17.91% |
| Weighted Average Cost of Capital (WACC) | 3.01% |
| Revenue Per Employee | 460.84M |
| Profits Per Employee | -274.23M |
| Employee Count | 256 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 1.41 |
Taxes
| Income Tax | -1.74B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.22% in the last 52 weeks. The beta is 0.16, so KRX:007460's price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | -97.22% |
| 50-Day Moving Average | 6,327.00 |
| 200-Day Moving Average | 9,219.45 |
| Relative Strength Index (RSI) | 39.65 |
| Average Volume (20 Days) | 570,417 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:007460 had revenue of KRW 117.97 billion and -70.20 billion in losses. Loss per share was -3,540.00.
| Revenue | 117.97B |
| Gross Profit | 31.17B |
| Operating Income | -95.57B |
| Pretax Income | -142.31B |
| Net Income | -70.20B |
| EBITDA | -71.97B |
| EBIT | -95.57B |
| Loss Per Share | -3,540.00 |
Balance Sheet
The company has 50.76 billion in cash and 187.86 billion in debt, with a net cash position of -137.10 billion or -6,665.25 per share.
| Cash & Cash Equivalents | 50.76B |
| Total Debt | 187.86B |
| Net Cash | -137.10B |
| Net Cash Per Share | -6,665.25 |
| Equity (Book Value) | 458.61B |
| Book Value Per Share | 7,708.38 |
| Working Capital | -5.13B |
Cash Flow
In the last 12 months, operating cash flow was -32.66 billion and capital expenditures -8.99 billion, giving a free cash flow of -41.65 billion.
| Operating Cash Flow | -32.66B |
| Capital Expenditures | -8.99B |
| Depreciation & Amortization | 23.60B |
| Net Borrowing | 101.47B |
| Free Cash Flow | -41.65B |
| FCF Per Share | -2,024.87 |
Margins
Gross margin is 26.42%, with operating and profit margins of -81.01% and -59.51%.
| Gross Margin | 26.42% |
| Operating Margin | -81.01% |
| Pretax Margin | -120.63% |
| Profit Margin | -59.51% |
| EBITDA Margin | -61.01% |
| EBIT Margin | -81.01% |
| FCF Margin | n/a |
Dividends & Yields
KRX:007460 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.24% |
| Shareholder Yield | -15.24% |
| Earnings Yield | -77.65% |
| FCF Yield | -46.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 28, 2022. It was a reverse split with a ratio of 0.3333333333.
| Last Split Date | Dec 28, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.3333333333 |
Scores
KRX:007460 has an Altman Z-Score of -0.72 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.72 |
| Piotroski F-Score | 2 |